Ayala Pharmaceuticals Inc (ADXS)

[Meishairwin]

With due respect to those few on this board who have experience in this world, few retail investors understand or appreciate what it takes to attract the best technical and executive talent in the booming world of biotech. I lived in Silicon Valley for 20+ and have done management consulting for 35 years, PhD from the Kellogg School, so I have some expertise along these lines.

Bottom line, what Dan did to increase the executive stock option compensation plan was critical to attract the quality technical and management talent necessary to make ADXS a huge success. High quality talent costs millions of dollars... usually supplied by stock grants and options, no cash (which is dear).

The rants of retail about "management getting rich" is generally nonsense. Sure, there are examples of CEO's and executives who milked a company that eventually went down, but those examples are rare. Generally, the outcome is binary: either the execs and technical talent walk away with little more than the income they received from decent (though rarely extraordinary) cash compensation, or they walk away multi-millionaires because they made a HUGE amount of money for the investors.

From all I can tell, Dan is pursuing a "big vision" outcome for ADXS because he believe the Lm technology will have a significant role in immuno-therapy. If you don't believe in his vision, then you ought not be investing in this company. And, that means buying into the need to attract the absolute best with hefty stock grants and options.